Oncolytics Biotech, Inc. (ONCY)

1.01 +0.04 (+3.80%) USD  |  NASDAQ  |  Jan 16, 16:00
1.05 +0.04 (+3.96%) Pre-Market: 20:00
More

Oncolytics Biotech SG&A Expense (% of Quarterly Revenues)

SG&A Expense (% of Quarterly Revenues) Chart

View SG&A Expense (% of Quarterly Revenues) for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years

View SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (% of Quarterly Revenues) Benchmarks

View SG&A Expense (% of Quarterly Revenues) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. --